Home › Funds › Velan Capital Investment Management LP › CRBP

Velan Capital Investment Management LP position in CRBP

CORBUS PHARMACEUTICALS HLDGS · Health Care

Velan Capital Investment Management LP reported holding 30,000 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS) in its Q3 2026 13F filing — a position valued at US$205K, representing 0.20% of its reported portfolio and ranking #33 among its reported holdings. Velan Capital Investment Management LP has disclosed CRBP holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)30.00K sh
Reported value held$204.60K
Portfolio Weight0.20%
First reportedQ3 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Velan Capital Investment Management LP's CRBP position evolved

Velan Capital Investment Management LP first disclosed a stake in CRBP in Q3 2024 at 50,000 shares (US$1.0M). Across 9 filings, Velan Capital Investment Management LP increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 30,000 shares valued at US$205K — an increase of 4,000 shares quarter over quarter.. Notable position changes include a 79% trim in Q4 2025 (shares rose 15% over the following quarter), a 100% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 50.00K $1.03M New
Q4 2024 56.70K $669.06K Add
Q1 2025 59.00K $313.29K Add
Q2 2025 59.00K $407.10K Hold
Q3 2025 61.00K $771.65K Add
Q4 2025 13.00K $105.82K Reduce
Q1 2026 26.00K $244.14K Add
Q2 2026 26.00K $243.88K Hold
Q3 2026 30.00K $204.60K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRBP and 13F data

CRBP (CORBUS PHARMACEUTICALS HLDGS) is a Health Care company. 22 other funds we track also report a position in CRBP — the largest reported positions include Cormorant Asset Management, LP (US$22.0M), Jones Hill Capital LP (US$6.0M), DIADEMA PARTNERS LP (US$5.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRBP

All CRBP fund holders →

FAQ

How long has Velan Capital Investment Management LP held CRBP?

Velan Capital Investment Management LP has disclosed CRBP holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Velan Capital Investment Management LP's current position in CRBP?

As of Q3 2026, Velan Capital Investment Management LP holds 30.00K shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), valued at $204.60K, representing 0.20% of its reported portfolio and ranking #33.

Has Velan Capital Investment Management LP been buying or selling CRBP?

In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP increased its position in CRBP.

Which other funds hold CRBP?

Other major institutional holders of CRBP include Cormorant Asset Management, LP, Jones Hill Capital LP, DIADEMA PARTNERS LP, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.